Known targets — ChEMBL curated mechanism
The experimentally established mechanism targets of Staurosporine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAP2K2 known ✓ | P36507 | 2/20 | 0.93 |
| ▸ | MAP2K1 known ✓ | Q02750 | 2/20 | 0.93 |
| ▸ | PRKCQ | Q04759 | 15/20 | 0.93 |
| ▸ | PRKD3 | O94806 | 10/20 | 0.93 |
| ▸ | PRKCG | P05129 | 10/20 | 0.93 |
| ▸ | PRKCZ | Q05513 | 10/20 | 0.93 |
| ▸ | PRKCD | Q05655 | 10/20 | 0.93 |
| ▸ | PRKCB | P05771 | 9/20 | 0.93 |
| ▸ | PRKCA | P17252 | 9/20 | 0.93 |
| ▸ | PRKCH | P24723 | 9/20 | 0.93 |
| ▸ | PRKCI | P41743 | 9/20 | 0.93 |
| ▸ | PRKCE | Q02156 | 9/20 | 0.93 |
| ▸ | PRKD1 | Q15139 | 9/20 | 0.93 |
| ▸ | ROCK2 | O75116 | 7/20 | 0.93 |
| ▸ | EGFR | P00533 | 7/20 | 0.93 |
| ▸ | PRKACA | P17612 | 7/20 | 0.93 |
| ▸ | PRKACG | P22612 | 6/20 | 0.93 |
| ▸ | PRKACB | P22694 | 6/20 | 0.93 |
| ▸ | SRC | P12931 | 4/20 | 0.93 |
| ▸ | CHEK1 | O14757 | 3/20 | 0.93 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Staurosporine SCHEMBL13621639 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL8156 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL17397398 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| SCHEMBL24393902 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL13659665 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL23793206 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL14264595 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL23768489 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL21312855 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD | |
| Staurosporine SCHEMBL8157 | 0.96 | PRKCQ (1.00) | PRKCQPRKD3PRKCGPRKCZPRKCD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2536720-A1 | TRIAZOLO [4, 5 - B]PYRIDIN DERIVATIVES | Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) | 2012-12-26 | — | — | EP | disclosed |
| WO-2012020217-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |
| WO-2012020215-A1 | AMINO- IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN OR LIPID KINASE INHIBITORS | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2012-02-16 | — | — | WO | disclosed |
| WO-2011101644-A1 | TRIAZOLO [4, 5 - B] PYRIDIN DERIVATIVES | CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS (CNIO) (ES) | 2011-08-25 | — | — | WO | disclosed |
| EP-2193133-A2 | IMIDAZOLOTHIADIAZOLES FOR USE AS PROTEIN KINASE INHIBITORS | Centro Nacional de Investigaciones Oncológicas (CNIO) (ES) | 2010-06-09 | — | — | EP | disclosed |
| WO-2009040552-A2 | SUBSTITUTED IMIDAZO (2, 1-B) -1, 3, 4-THIAZOLE COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES THEREOF | CENTRO NACIONAL DE INVESTIGACIONES ONCOLÓGICAS (CNIO) (ES) | 2009-04-02 | — | — | WO | disclosed |